Equities research analysts at William Blair Rated shares of Tornier BV (NASDAQ: TRNX) a “Outperform” rating in a research note released to investors today.
Tornier N.V. operates as a medical device company offering products that treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The Company’s products are organized in four major categories: upper extremity joints and trauma, lower extremity joints and trauma, sports medicine and orthobiologics, and large joints and other. The upper extremity products include joint replacement and bone fixation devices for the shoulder, hand, wrist and elbow; lower extremity products include joint replacement and bone fixation devices for the foot and ankle; sports medicine and orthobiologics product category includes products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries; and large joints and other products include hip and knee joint replacement implants and ancillary products. Tornier N.V. is based in Amsterdam, The Netherlands.
Shares of Tornier BV (NASDAQ: TRNX) are trading down -2.12% as of Mar 16, 12:54PM EDT, hitting 18.60. Tornier BV has a 52 week low of 17.80 and a 52 week high of 19.17. The companies last released earnings were -1.43 per share. were The company has a market cap of 706.58M and a price-to-earnings ratio of .
FavStocks.com – Tornier BV (TRNX) Rated at “Outperform” by William Blair
Contributed by FavStocks Staff
Please visit FavStocks.com for more info on your Favorite Stocks. Also stop by the free Stock Forum and discuss todays hot stocks. )
Negocioenlinea
min2664
No comments:
Post a Comment